Full Press Release Details
BridgeBio Pharma Announces Acoramidis Phase 3 ATTRibute-CM Data Presented At AHA And Published In NEJM.
BBIO
BridgeBio Pharma Announces Acoramidis Phase 3 ATTRibute-CM Data Presented At AHA And Published In NEJM
Key Takeaway: BridgeBio Pharma Announces Acoramidis Phase 3 ATTRibute-CM Data Presented At AHA And Published In NEJM